|
|
|
| Effect of Transrectal Ultrasound Elastography Combined with Prostate Biopsy on Detection Rate of Prostate Cancer |
| ZHANG Guiping, WEI Jie, XU Jie, et al |
| Hefei Second People's Hospital, Anhui Hefei 230011, China |
|
|
|
|
Abstract Objective: To investigate the effect of transrectal Ultrasound Elastography (TRE) combined with prostate biopsy on the detection rate of prostate cancer (PCa), and to provide reference for clinical optimal diagnosis. Methods: 110 patients with suspected prostate cancer were examined by transrectal Ultrasound (TRUS) and TRE respectively, and puncture biopsy guided by TRUS was performed to compare the diagnostic effect of the two methods on PCa. Result: 53 cases Of 110 suspected PCa patients were diagnosed pathologically, accounting for 48.18% (53/110), 49 were benign prostatic hyperplasia (BPH), accounting for 44.55% (49/110), and 8 were chronic prostatitis (CP), accounting for 7.27% (8/110). The sensitivity, specificity and accuracy of TRUS-guided puncture biopsy in the diagnosis of PCa were 75.47% (40/53), 68.42% (39/57), 71.82% (79/110), and the positive and negative predictive values were 68.97% (40/58) and 75.00% (39/52), respectively, which were significantly lower than those of TRE-guided puncture biopsy in the diagnosis of PCa 92.45% (49/53), 94.74% (54/57), 93.64% (103/110), 94.23% (49/52), 93.10% (54/58), the difference was statistically significant (X2= 5.675, 13.134, 18.323, 11.331, 6.877, P<0.05 or <0.001), the number of needles under TRUS guidance was 815, the positive rate of puncture point was 18.77%(153/815), significantly lower than that under TRE guidance, the positive rate of target puncture point was 51.33% (116/226), the difference was statistically significant (X2 = 150.418, P<0.001). Conclusion: TRE-guided prostate biopsy can achieve the target biopsy of the lesion, improve the detection rate of PCa and positive rate of puncture point. It can be used as an effective means of early screening and diagnosis of PCa, and is worthy of clinical application.
|
|
|
|
|
|
[1] 曹德宏,柳良仁,魏强,等.前列腺癌的治疗研究进展[J].华西医学,2017,32(2):277~281.
[2] 齐金蕾,王黎君,周脉耕,等.1990-2013年中国男性前列腺癌疾病负担分析[J].中华流行病学杂志,2016,37(6):778~782.
[3] Zhang J,Hao X,Yang Y,et al.Evaluation of supplementary diagnostic value of contrast-enhanced ultrasound for lymph node puncture biopsy[J].Journal of Thoracic Disease,2017,9(11):4791.
[4] 那彦群,叶章群,孙光.2011版中国泌尿外科疾病诊断治疗指南[M].人民卫生出版社,2011.
[5] Washino S,Okochi T,Saito K,et al.Combination of prostate imaging reporting and data system(PI-RADS)score and prostate-specific antigen(PSA)density predicts biopsy outcome in prostate biopsy naive patients[J].Bju International,2016,119(2):225~233.
[6] 娄小嫣,曾家元,张名均.超声弹性成像技术与常规超声在前列腺癌和前列腺增生诊断中的应用对比研究[J].中国男科学杂志,2016,30(1):25~29.
[7] 韩友东,李开龙,张磊,等.超声弹性成像技术联合核磁共振减少前列腺活检穿刺针数的临床研究[J].现代医学,2016,44(5):689~693.
[8] Kratzenberg J,Salomon G,Tennstedt P,et al.Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs.systematic biopsy[J].World Journal of Urology,2018,36(1):1~6. |
|
|
|
2019, Vol. 25 
